No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia

Neurobiol Aging. 2007 Nov;28(11):1789-90. doi: 10.1016/j.neurobiolaging.2006.07.016. Epub 2006 Sep 18.

Abstract

Mutations of the chromatin modifying protein 2B gene (CHMP2B) were identified, in a Danish pedigree, to cause familial frontotemporal dementia (FTD). To explore the possible genetic contribution of common CHMP2B variants in sporadic FTD, we analyzed 14 single nucleotide polymorphisms covering the entire genomic region of CHMP2B. After adjustment for multiple testing single marker and haplotype analysis revealed no significant association with sporadic FTD. Thus, we conclude that CHMP2B can be excluded as a susceptibility gene conferring risk to sporadic forms of FTD.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Dementia / genetics*
  • Dementia / metabolism*
  • Endosomal Sorting Complexes Required for Transport
  • Genetic Predisposition to Disease
  • Genetic Variation / genetics
  • Haplotypes / genetics
  • Humans
  • Middle Aged
  • Nerve Tissue Proteins / genetics*
  • Polymorphism, Single Nucleotide / genetics

Substances

  • CHMP2B protein, human
  • Endosomal Sorting Complexes Required for Transport
  • Nerve Tissue Proteins